Author:
Anis Emilia,Preis Sharon Alroy,Cedar Noa,Tal Yuval,Hershkowitz Isca,Hershko Alon Y.
Reference18 articles.
1. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020
2. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach;Banerji;J Allergy Clin Immunol Pract,2021
3. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020;Shimabukuro;Am J Transplant,2021
4. Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine;Shimabukuro;JAMA,2021
5. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine - United states, December 21, 2020-January 10, 2021;Shimabukuro;Am J Transplant,2021